These findings suggest that the regulatory axis involving PRAME-AS, MZF1, and epigenetic elements such as CpG islands plays a pivotal role in PRAME regulation in cancers, highlighting PRAME-AS as a potential key contributor to tumor processes. The gene discussed is PRAME-AS; the disease is cancer.